Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced Solid Tumor

Explore clinical trials studying Locally Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

31 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced Solid Tumor trial results

Recruiting

CD8 PET Imaging in Metastatic Solid Tumours

NCT06534190

Conditions
Locally Advanced Solid Tumor
Locations
  • VUMC Amsterdam, Netherlands
  • University Medical Center Groningen Groningen, Netherlands
  • Vall d'Hebron Institute of Oncology (VHIO) / Vall d'Hebron Institute Research (VHIR) Barcelona, Spain
  • University of Cambridge Cambridge, United Kingdom
View Trial Details
Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

NCT05118789

Conditions
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • UCI Medical Center Orange, California, United States
  • Stanford Medicine Palo Alto, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
View all 63 locations
View Trial Details
Recruiting

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

NCT06415487

Conditions
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • University of California San Diego San Diego, California, United States
  • SCRI Denver Drug Development Unit Denver, Colorado, United States
  • Sarah Cannon Research Institute (SCRI) Oncology Partners Nashville, Tennessee, United States
  • Texas Oncology Dallas, Texas, United States
View Trial Details
Completed

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

NCT03881488

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • Ocala Oncology Center Ocala, Florida, United States
  • Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

NCT04975958

Conditions
Locally Advanced Solid Tumor
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists - Lake Mary Cancer Center Lake Mary, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • NYU Grossman School of Medicine New York, United States
View Trial Details
Completed

A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib

NCT04814667

Conditions
Locally Advanced Solid Tumor, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations
  • CHU Amiens Amiens, France
  • Centre Georges Francois Leclerc Dijon, France
  • Centre Leon Berard Lyon, France
  • Chi Elbeuf Louviers Saint-Aubin-lès-Elbeuf, France
View Trial Details

Related conditions